FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2920794977> ?p ?o ?g. }

• W2920794977 endingPage "3624" @default.
• W2920794977 startingPage "3624" @default.
• W2920794977 abstract "Abstract Transferrin receptor 2 (TFR2), the type 3 hemochromatosis gene, is an activator of the iron hormone hepcidin in the liver and a partner of erythropoietin (EPO) receptor in erythroid cells. The loss of bone marrow (BM) Tfr2 increases erythroblast EPO sensitivity inducing erythrocytosis in mice (Nai et al, Blood 2015). We explored whether deletion of BM Tfr2 improves anemia and ineffective erythropoiesis in β-thalassemias, iron-loading anemias due to recessive β-globin gene mutations. We generated thalassemic mice (Hbbth3/+) with selective BM inactivation of Tfr2 (Tfr2BMKO/Hbbth3/+) through BM transplantation (BMT). Deletion of BM Tfr2 ameliorates RBC morphology with consistent and persistent increase of RBC count and Hb levels in thalassemic mice, accompanied by reduced iron accumulation. Around 22 weeks after BMT the improvement fades in double mutantanimals: Hb levels return comparable to those of Hbbth3/+mice, while RBC count persists higher. Anemia improvement in double mutant mice reduces serum EPO levels and improves erythropoiesis, in particular 22 weeks after BMT. Overall these data prove that the loss of the beneficial effect of deleting Tfr2 is not accounted for by erythropoiesis failure, but likely by exhaustion of splenic iron consumed by the enhanced erythropoiesis. In order to elucidate the molecular mechanisms of the phenotype improvement, we investigated whether the EPO-EPOR signaling pathway is overactive, as occurs in Tfr2 null erythroid cells (Nai et al, Blood 2015). Taking into account that Tfr2BMKO/Hbbth3/+ mice have lower serum EPO than Hbbth3/+, the expression levels of target genes of the EPOR-JAK2-STAT5 (Erfe and Bcl-xl) and of EPOR-PI3K-AKT pathway (Fasl, Epor and Ccng2) is consistent with the signaling being inappropriately active in double mutant mice. To start unraveling the global molecular/cellular processes underlying the remarkable phenotype amelioration, we performed RNAseq analysis on spleen samples from double mutant and Hbbth3/+ control mice at the time point of maximal erythropoiesis improvement (22 weeks post BMT). Spleens are enlarged in both genotypes with about 80% Ter119+ (erythroid) cells in both. In total we identified 2796 genes (1997 protein coding) differentially regulated between the two genotypes. The analysis of iron-related genes reveals a strong reduction of the expression of the iron exporter Fpn, Hmox1 and Alas2, suggestive of decreased hemolysis and/or of free heme accumulation in double mutants. Gene ontology analysis reveals enrichment of genes involved in cell cycle and proliferation, mitochondrial function, as well as proteasome activity and of most of the antioxidant targets (Sod1, Sod2, Fth1, Txn1, Txn2, Gstpi) of the canonical NF-kB pathway. Underrepresented genes are those involved in lipid handling, leukocyte/lymphocyte differentiation and coagulation. In summary, the RNAseq patterns indicate an increased spleen erythroid commitment and a mitochondrial metabolic shift, similar to the shift occurring during hematopoietic development to sustain erythroid proliferation and differentiation. We speculate that this effect is mediated by the enhanced EPO sensitivity. Interestingly EPO directly stimulates mitochondrial genes expression in adipocytes. Also the increased proteasome activity may significantly contribute to the improved erythropoiesis, since proteasomal degradation is required in the process of erythroblast enucleation. Finally, the activation of the NF-kB antioxidant response may contrast ROS increase and limit ineffective erythropoiesis. In conclusion, targeting erythroid TFR2 might become a novel erythropoiesis stimulating approach, worth to be tested in other forms of anemia. Disclosures Muckenthaler: Novartis: Research Funding. Camaschella:vifor Pharma: Honoraria, Membership on an entity's Board of Directors or advisory committees." @default.
• W2920794977 created "2019-03-22" @default.
• W2920794977 creator A5005334724 @default.
• W2920794977 creator A5011774850 @default.
• W2920794977 creator A5032248260 @default.
• W2920794977 creator A5050709615 @default.
• W2920794977 creator A5057071664 @default.
• W2920794977 creator A5060970793 @default.
• W2920794977 creator A5065413660 @default.
• W2920794977 creator A5075889001 @default.
• W2920794977 creator A5081960790 @default.
• W2920794977 creator A5082550914 @default.
• W2920794977 date "2018-11-29" @default.
• W2920794977 modified "2023-10-01" @default.
• W2920794977 title "Exploring the Mechanisms of Thalassemic Erythropoiesis Improvement Caused By Bone Marrow Tfr2 Deletion" @default.
• W2920794977 doi "https://doi.org/10.1182/blood-2018-99-115835" @default.
• W2920794977 hasPublicationYear "2018" @default.
• W2920794977 type Work @default.
• W2920794977 sameAs 2920794977 @default.
• W2920794977 citedByCount "0" @default.
• W2920794977 crossrefType "journal-article" @default.
• W2920794977 hasAuthorship W2920794977A5005334724 @default.
• W2920794977 hasAuthorship W2920794977A5011774850 @default.
• W2920794977 hasAuthorship W2920794977A5032248260 @default.
• W2920794977 hasAuthorship W2920794977A5050709615 @default.
• W2920794977 hasAuthorship W2920794977A5057071664 @default.
• W2920794977 hasAuthorship W2920794977A5060970793 @default.
• W2920794977 hasAuthorship W2920794977A5065413660 @default.
• W2920794977 hasAuthorship W2920794977A5075889001 @default.
• W2920794977 hasAuthorship W2920794977A5081960790 @default.
• W2920794977 hasAuthorship W2920794977A5082550914 @default.
• W2920794977 hasBestOaLocation W29207949771 @default.
• W2920794977 hasConcept C126322002 @default.
• W2920794977 hasConcept C134018914 @default.
• W2920794977 hasConcept C170493617 @default.
• W2920794977 hasConcept C203014093 @default.
• W2920794977 hasConcept C2776485076 @default.
• W2920794977 hasConcept C2776768029 @default.
• W2920794977 hasConcept C2777417653 @default.
• W2920794977 hasConcept C2778248108 @default.
• W2920794977 hasConcept C2778534260 @default.
• W2920794977 hasConcept C2779703530 @default.
• W2920794977 hasConcept C2780007613 @default.
• W2920794977 hasConcept C2780844101 @default.
• W2920794977 hasConcept C2909030593 @default.
• W2920794977 hasConcept C3019673199 @default.
• W2920794977 hasConcept C31102739 @default.
• W2920794977 hasConcept C32264632 @default.
• W2920794977 hasConcept C71924100 @default.
• W2920794977 hasConcept C86803240 @default.
• W2920794977 hasConceptScore W2920794977C126322002 @default.
• W2920794977 hasConceptScore W2920794977C134018914 @default.
• W2920794977 hasConceptScore W2920794977C170493617 @default.
• W2920794977 hasConceptScore W2920794977C203014093 @default.
• W2920794977 hasConceptScore W2920794977C2776485076 @default.
• W2920794977 hasConceptScore W2920794977C2776768029 @default.
• W2920794977 hasConceptScore W2920794977C2777417653 @default.
• W2920794977 hasConceptScore W2920794977C2778248108 @default.
• W2920794977 hasConceptScore W2920794977C2778534260 @default.
• W2920794977 hasConceptScore W2920794977C2779703530 @default.
• W2920794977 hasConceptScore W2920794977C2780007613 @default.
• W2920794977 hasConceptScore W2920794977C2780844101 @default.
• W2920794977 hasConceptScore W2920794977C2909030593 @default.
• W2920794977 hasConceptScore W2920794977C3019673199 @default.
• W2920794977 hasConceptScore W2920794977C31102739 @default.
• W2920794977 hasConceptScore W2920794977C32264632 @default.
• W2920794977 hasConceptScore W2920794977C71924100 @default.
• W2920794977 hasConceptScore W2920794977C86803240 @default.
• W2920794977 hasIssue "Supplement 1" @default.
• W2920794977 hasLocation W29207949771 @default.
• W2920794977 hasOpenAccess W2920794977 @default.
• W2920794977 hasPrimaryLocation W29207949771 @default.
• W2920794977 hasRelatedWork W1979992739 @default.
• W2920794977 hasRelatedWork W2026199006 @default.
• W2920794977 hasRelatedWork W2417997341 @default.
• W2920794977 hasRelatedWork W2592379775 @default.
• W2920794977 hasRelatedWork W2920794977 @default.
• W2920794977 hasRelatedWork W2950253990 @default.
• W2920794977 hasRelatedWork W2980551723 @default.
• W2920794977 hasRelatedWork W2991763043 @default.
• W2920794977 hasRelatedWork W4361000242 @default.
• W2920794977 hasRelatedWork W236321232 @default.
• W2920794977 hasVolume "132" @default.
• W2920794977 isParatext "false" @default.
• W2920794977 isRetracted "false" @default.
• W2920794977 magId "2920794977" @default.
• W2920794977 workType "article" @default.